Real-world use and effectiveness of adjuvant trastuzumab in 2665 consecutive breast cancer patients

被引：0
|
作者：
Tjan-Heijnen, V. C. G.
Seferina, S. C.
Lobbezoo, D. J. A.
Voogd, A. C.
Dercksen, M. W.
van den Berkmortel, F.
van Kampen, R. J. W.
van de Wouw, A. J.
Joore, M. A.
Borm, G. F.
机构：
[1] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Limburg, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Limburg, Netherlands
[3] Maxima Med Ctr, Veldhoven, Brabant, Netherlands
[4] Atrium Med Ctr Parkstad, Heerlen, Limburg, Netherlands
[5] Orbis Med Ctr, Sittard Geleen, Limburg, Netherlands
[6] VieCuri Med Ctr, Venlo, Limburg, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Gelderland, Netherlands
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS-12-P5-21-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-21-04
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+Metastatic Breast Cancer: The DE-REAL Study
    Botticelli, Andrea
    Caputo, Roberta
    Scagnoli, Simone
    Pisegna, Simona
    De Laurentiis, Michelino
    Curigliano, Giuseppe
    Lambertini, Matteo
    Pantano, Francesco
    Palazzo, Antonella
    Paris, Ida
    Vernieri, Claudio
    Tedesco, Beatrice
    Giampaglia, Marianna
    Palleschi, Michela
    Ballatore, Zelmira
    Alesini, Daniele
    D'Auria, Giuliana
    Fabbri, Agnese
    Rossi, Luigi
    Verrazzo, Annarita
    Scafetta, Roberta
    Marinelli, Daniele
    Sposetti, Caterina
    Barberi, Vittoria
    Strigari, Lidia
    Marchetti, Paolo
    Santini, Daniele
    Fabi, Alessandra
    ONCOLOGIST, 2024, 29 (04): : 303 - 310
  • [32] Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer
    Skinner, Karen E.
    Olufade, Temitope
    Walker, Mark S.
    Schwartzberg, Lee S.
    BREAST JOURNAL, 2020, 26 (02): : 112 - 119
  • [33] Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer
    Skinner, Karen E.
    Haiderali, Amin
    Huang, Min
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (08) : 931 - 942
  • [34] Real-world effectiveness of ribociclib in metastatic breast cancer patients: Does dose affect survival?
    Fernandez-Cuerva, Cristina
    Chinchilla-Alarcon, Teresa
    Jose Alcaraz-Sanchez, Juan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1619 - 1627
  • [35] Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy
    Telli, Tugba Akin
    Ozturk, Mehmet Akif
    Alan, Ozkan
    Hasanov, Rahib
    Kostek, Osman
    Arikan, Rukiye
    Basoglu, Tugba
    Kaya, Serap
    Ercelep, Ozlem
    Babacan, Nalan Akgul
    Dane, Faysal
    Yumuk, Perran Fulden
    FUTURE ONCOLOGY, 2022, 18 (22) : 2425 - 2439
  • [36] Real-World Analysis of Breast Cancer Patients Qualifying for Adjuvant CDK4/6 Inhibitors
    Kanjanapan, Yada
    Anderson, Wayne
    Smith, Mirka
    Green, Jenny
    Chalker, Elizabeth
    Craft, Paul
    CLINICAL BREAST CANCER, 2025, 25 (02)
  • [37] Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population
    Gagliato, Debora
    Reinert, Tomas
    Rocha, Claudio
    Tavares, Monique
    Pimentel, Samio
    Fuzita, William
    Araujo, Marcia
    Matias, Danielli
    Aleixo, Sabina
    Franca, Bruno
    Magaton, Erida
    Brito, Natalia
    Cardoso, Ana Carolina
    Castilho, Vivienne
    ONCOLOGY AND THERAPY, 2024, 12 (03) : 437 - 449
  • [38] Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study
    Jin Zhang
    Hongchuan Jiang
    Jian Zhang
    Guoqiang Bao
    Guoqiang Zhang
    Haibo Wang
    Xi Wang
    BMC Cancer, 21
  • [39] Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study
    Zhang, Jin
    Jiang, Hongchuan
    Zhang, Jian
    Bao, Guoqiang
    Zhang, Guoqiang
    Wang, Haibo
    Wang, Xi
    BMC CANCER, 2021, 21 (01)
  • [40] Evidence of real-world effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women.
    Du, XL
    Jones, D
    Goodwin, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S37 - S37
12345